Neil Chanchlani

2.9k total citations
43 papers, 348 citations indexed

About

Neil Chanchlani is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Neil Chanchlani has authored 43 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 12 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in Neil Chanchlani's work include Inflammatory Bowel Disease (16 papers), Microscopic Colitis (10 papers) and Biosimilars and Bioanalytical Methods (6 papers). Neil Chanchlani is often cited by papers focused on Inflammatory Bowel Disease (16 papers), Microscopic Colitis (10 papers) and Biosimilars and Bioanalytical Methods (6 papers). Neil Chanchlani collaborates with scholars based in United Kingdom, United States and Canada. Neil Chanchlani's co-authors include Peter J. Gill, Francine Buchanan, James Goodhand, Nicholas A. Kennedy, Simeng Lin, Tariq Ahmad, George D. Kitas, Claire Bewshea, Karen Douglas and James Hodson and has published in prestigious journals such as Gut, BMJ and The Journal of Pediatrics.

In The Last Decade

Neil Chanchlani

36 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neil Chanchlani United Kingdom 11 105 77 51 51 46 43 348
Turki AlAmeel Saudi Arabia 11 104 1.0× 63 0.8× 26 0.5× 69 1.4× 58 1.3× 37 343
S. Leone Italy 13 165 1.6× 130 1.7× 60 1.2× 29 0.6× 58 1.3× 42 456
Jaime Cruz‐Rojo Spain 13 144 1.4× 104 1.4× 50 1.0× 110 2.2× 103 2.2× 29 614
Elina Medvedeva United States 13 58 0.6× 141 1.8× 27 0.5× 49 1.0× 140 3.0× 29 445
Xinchan Jiang Hong Kong 11 34 0.3× 62 0.8× 24 0.5× 18 0.4× 100 2.2× 16 347
Sarah Finlayson Canada 17 106 1.0× 216 2.8× 34 0.7× 73 1.4× 42 0.9× 34 1.2k
Catharina Sarkkola Finland 6 61 0.6× 93 1.2× 9 0.2× 24 0.5× 36 0.8× 8 354
Louise Heuzenroeder Australia 8 21 0.2× 55 0.7× 42 0.8× 62 1.2× 70 1.5× 10 357
Sofia Franco United States 13 32 0.3× 79 1.0× 78 1.5× 38 0.7× 79 1.7× 26 598
Helymar da Costa Machado Brazil 13 19 0.2× 73 0.9× 23 0.5× 41 0.8× 53 1.2× 53 511

Countries citing papers authored by Neil Chanchlani

Since Specialization
Citations

This map shows the geographic impact of Neil Chanchlani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil Chanchlani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil Chanchlani more than expected).

Fields of papers citing papers by Neil Chanchlani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil Chanchlani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil Chanchlani. The network helps show where Neil Chanchlani may publish in the future.

Co-authorship network of co-authors of Neil Chanchlani

This figure shows the co-authorship network connecting the top 25 collaborators of Neil Chanchlani. A scholar is included among the top collaborators of Neil Chanchlani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil Chanchlani. Neil Chanchlani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lin, Simeng, Neil Chanchlani, Callum M. Roberts, et al.. (2023). P662 Pre-treatment vitamin D concentrations do not predict therapeutic outcome to anti-TNF therapies in biologic-naïve patients with active luminal Crohn’s disease. Journal of Crohn s and Colitis. 17(Supplement_1). i791–i793. 1 indexed citations
3.
Lin, Simeng, Eilís Hannon, Jeffrey F. Waring, et al.. (2023). DOP88 Understanding the molecular mechanisms of anti-TNF treatment failure: Whole blood DNA methylation changes associated with primary non-response to anti-TNF treatment in patients with Crohn’s disease. Journal of Crohn s and Colitis. 17(Supplement_1). i164–i166. 2 indexed citations
4.
Lin, Simeng, Eilís Hannon, Mark Reppell, et al.. (2023). Whole Blood DNA Methylation Changes Are Associated with Anti-TNF Drug Concentration in Patients with Crohn’s Disease. Journal of Crohn s and Colitis. 18(8). 1190–1201. 7 indexed citations
5.
Chanchlani, Neil, Simeng Lin, Rachel Nice, et al.. (2023). Pretreatment Vitamin D Concentrations Do Not Predict Therapeutic Outcome to Anti-TNF Therapies in Biologic-Naïve Patients With Active Luminal Crohn’s Disease. Crohn s & Colitis 360. 5(3). otad026–otad026. 5 indexed citations
6.
7.
Lin, Simeng, Louis Ho Shing Lau, Neil Chanchlani, Nicholas A. Kennedy, & Siew C. Ng. (2022). Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic. Gut. 71(7). 1426–1439. 15 indexed citations
8.
Chanchlani, Neil, Simeng Lin, Benjamin Hamilton, et al.. (2021). HMO-4 Immunogenicity to second anti-TNF therapy (IMSAT): implications for sequencing of biologic therapy. A31.2–A32.
9.
Chee, Desmond, Rachel Nice, Benjamin Hamilton, et al.. (2021). Patient-led Remote IntraCapillary pharmacoKinetic Sampling (fingerPRICKS) for Therapeutic Drug Monitoring in patients with Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 16(2). 190–198. 6 indexed citations
10.
Chanchlani, Neil, et al.. (2021). Langerhans cell histiocytosis in a 5-month-old baby. Canadian Medical Association Journal. 193(1). E23–E23. 1 indexed citations
11.
Walker, G, Neil Chanchlani, Amanda Thomas, et al.. (2020). Primary care faecal calprotectin testing in children with suspected inflammatory bowel disease: a diagnostic accuracy study. Archives of Disease in Childhood. 105(10). 957–963. 5 indexed citations
12.
Walker, G, Simeng Lin, Neil Chanchlani, et al.. (2020). Quality improvement project identifies factors associated with delay in IBD diagnosis. Alimentary Pharmacology & Therapeutics. 52(3). 471–480. 20 indexed citations
13.
Nice, Rachel, Neil Chanchlani, Harry Green, et al.. (2020). Validating the positivity thresholds of drug‐tolerant anti‐infliximab and anti‐adalimumab antibody assays. Alimentary Pharmacology & Therapeutics. 53(1). 128–137. 10 indexed citations
14.
Chee, Desmond, Benjamin Hamilton, Neel Heerasing, et al.. (2020). Root‐cause analyses of missed opportunities for the diagnosis of colorectal cancer in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 53(2). 291–301. 16 indexed citations
15.
Hamilton, Benjamin, Harry Green, Neel Heerasing, et al.. (2020). Incidence and prevalence of inflammatory bowel disease in Devon, UK. Frontline Gastroenterology. 12(6). 461–470. 18 indexed citations
16.
Chanchlani, Neil, Linda Williams, Rafeeq Muhammed, et al.. (2018). Use of Infliximab Biosimilar Versus Originator in a Pediatric United Kingdom Inflammatory Bowel Disease Induction Cohort. Journal of Pediatric Gastroenterology and Nutrition. 67(4). 513–519. 21 indexed citations
17.
Wolfe, Ingrid, Louise Sigfrid, Neil Chanchlani, & Simon Lenton. (2016). Child Health Systems in the United Kingdom (England). The Journal of Pediatrics. 177. S217–S242. 15 indexed citations
18.
Chanchlani, Neil, et al.. (2015). G154(P) Transition of patients with sickle cell disease – how can we help? results of a survey of adolescents recently transferred to adult services. Archives of Disease in Childhood. 100(Suppl 3). A66.2–A66. 1 indexed citations
19.
Sandoo, Aamer, Neil Chanchlani, James Hodson, et al.. (2014). The relationship between cardiovascular disease risk prediction scores and vascular function and morphology in rheumatoid arthritis.. PubMed. 32(6). 914–21. 4 indexed citations
20.
Chanchlani, Neil. (2011). One man, one woman. BMJ. d7620–d7620.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Turki AlAmeel Breakdown of academic impact, for papers by S. Leone Breakdown of academic impact, for papers by Jaime Cruz‐Rojo Breakdown of academic impact, for papers by Elina Medvedeva Breakdown of academic impact, for papers by Xinchan Jiang Breakdown of academic impact, for papers by Sarah Finlayson Breakdown of academic impact, for papers by Catharina Sarkkola Breakdown of academic impact, for papers by Louise Heuzenroeder Breakdown of academic impact, for papers by Sofia Franco Breakdown of academic impact, for papers by Helymar da Costa Machado
Rankless by CCL
2026